Hepatic Arterial Infusion Chemotherapy Using the Port System in Advanced Gallbladder Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Gallbladder (GB) cancer is relatively rare and has a poor prognosis, with a median survival time of less than 3 months. It is resistant to chemotherapy. Therefore, the role of systemic chemotherapy is limited. However, administering the anticancer agent directly into the hepatic artery can result in a higher drug concentration in the cancer tissue. In this paper, we report a case of advanced GB cancer treated with hepatic arterial infusion chemotherapy (HAIC) using the port system. The patient received six cycles of HAIC with 5-fluorouracil (750 mg/m2) and cisplatin (25 mg/m2); each cycle lasted for 4 days every month. The tumor showed objective response during HAIC, and the patient survived for 15 months from the first therapy. HAIC using the port system might be a promising therapeutic modality for treating locally advanced GB cancer.
Abstract
Gallbladder (GB) cancer is relatively rare and has a poor prognosis, with a median survival time of less than 3 months. It is resistant to chemotherapy. Therefore, the role of systemic chemotherapy is limited. However, administering the anticancer agent directly into the hepatic artery can result in a higher drug concentration in the cancer tissue. In this paper, we report a case of advanced GB cancer treated with hepatic arterial infusion chemotherapy (HAIC) using the port system. The patient received six cycles of HAIC with 5-fluorouracil (750 mg/m2) and cisplatin (25 mg/m2); each cycle lasted for 4 days every month. The tumor showed objective response during HAIC, and the patient survived for 15 months from the first therapy. HAIC using the port system might be a promising therapeutic modality for treating locally advanced GB cancer.
참고문헌 (10)
- Cubertafond P, "Surgical treatment of 724 carcinomas of gall bladder. Results of the French Surgical Association Survey", Ann Surg, 219, pp.275~280 (1994)[DOI]
- Zhu AX, "Current management of gallbladder carcinoma", Oncologist, 15, pp.168~181 (2010)[DOI]
- Todoroki T, "Chemotherapy for gallbladder carcinoma--a surgeon's perspective", Hepatogastroenterology, 47, pp.948~955 (2000)
- Ando E, "Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases", Cancer, 95, pp.588~595 (2002)[DOI]
- Eun JR, "Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-<TEX>${\alpha}$<", TEX> for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis, 2009, pp.44, 1479~1486
- Bode MK, "Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: a follow-up study", J Surg Oncol, 91, pp.102~106 (2005)[DOI]
- Kato Y, "Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers", Anticancer Res, 25, pp.477~482 (2005)
- undefined, "Practice guidelines for management of hepatocellular carcinoma 2009", The Korean Journal of Hepatology, 15(3), pp.391~ (2009), The Korean Association for the Study of the Liver[DOI]
- Urabe T, "Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon alpha-2b for patients with locally advanced hepatocellular carcinoma", Oncology, 55, pp.39~47 (1998)[DOI]
- Chatni SS, "Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally advanced and metastatic gallbladder cancer", J Cancer Res Ther, 4, pp.151~155 (2008)[DOI]